Valuation: DEEPVERGE

Market Cap 8.75M 7.81M 7.21M 6.54M 12.23M 830M 12.43M 86.82M 34.37M 435M 32.82M 32.12M 1.37B P/E 2020
-12.5x
P/E 2021 -19.3x
Enterprise Value 9.18M 8.2M 7.57M 6.86M 12.84M 871M 13.05M 91.12M 36.08M 457M 34.45M 33.72M 1.44B EV / Sales 2020
10x
EV / Sales 2021 6.11x
Free-Float
90.54%
Yield 2020 *
-
Yield 2021 -
5 years 0
Extreme 0.0005
0.34
10 years 0
Extreme 0.0005
0.42
Manager TitleAgeSince
Chief Executive Officer 68 2022-10-31
Director of Finance/CFO - 2018-08-29
Sales & Marketing 53 2021-07-11
Director TitleAgeSince
Chairman 66 2019-05-20
Director/Board Member 68 2020-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
11/16/22 Free

Executive/Senior Manager

162,500 0.0740%
11/16/22 Buy

Chief Financial Officer

2,000,000 0.9103%
11/16/22 Buy

Executive/Senior Manager

650,000 0.2958%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 421K
-1.29%+1.59%+18.23%+76.66% 761B
+0.11%+4.71%+16.33%+79.18% 87.42B
-1.00%+6.75%+20.22%+168.83% 68.79B
-0.83%+0.76%-17.99%+6.88% 48.93B
-2.95%-1.54%-2.38%+74.69% 47.77B
+0.39%-2.91%+51.34%+703.30% 43.63B
+0.41%+4.06%+9.41%+37.48% 32.32B
-1.50%+2.05%+43.45%+71.22% 27.25B
-2.14%+4.64%-59.86%-54.61% 25.64B
Average -0.88%+1.19%+7.88%+116.36% 114.23B
Weighted average by Cap. -1.13%+2.89%+15.66%+99.08%

Financials

2020 2021
Net sales 4.48M 4M 3.7M 3.35M 6.27M 426M 6.37M 44.5M 17.62M 223M 16.82M 16.47M 703M 9.3M 8.3M 7.67M 6.95M 13M 883M 13.22M 92.29M 36.54M 462M 34.89M 34.15M 1.46B
Net income -2.72M -2.43M -2.24M -2.03M -3.8M -258M -3.86M -26.98M -10.68M -135M -10.2M -9.98M -426M -2.68M -2.39M -2.21M -2M -3.75M -254M -3.81M -26.6M -10.53M -133M -10.05M -9.84M -420M
Net Debt 1.11M 994K 918K 832K 1.56M 106M 1.58M 11.05M 4.37M 55.36M 4.18M 4.09M 175M 434K 388K 358K 324K 607K 41.2M 617K 4.31M 1.71M 21.59M 1.63M 1.59M 68.05M
Logo DEEPVERGE
Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.
Employees
73